Tim Henkel

Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens

Issam Raad, Rabih O. Darouiche, José A. Vázquez et al. · Clinical Infectious Diseases · 2005 · 292 citations · Full text

A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis

David S. Krause, A. E. Simjee, C.E.J. Van Rensburg et al. · Clinical Infectious Diseases · 2004 · 243 citations · Full text

Antifungal Agent, Antifungal Agents, Double-blind Trial +10

Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections

Elyse Seltzer, MaryBeth Dorr, Beth P. Goldstein et al. · Clinical Infectious Diseases · 2003 · 233 citations

Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal

James A. Dowell, William Knebel, Tom Ludden et al. · The Journal of Clinical Pharmacology · 2004 · 168 citations

Serious Fungal Disease, Analysis Population, Antifungal Agent +8

Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants

Peter Westervelt, Tim Henkel, D B Trowbridge et al. · Journal of Virology · 1992 · 114 citations · Full text

Viral Replication, Innate Immune System, Immunology +16